159 related articles for article (PubMed ID: 24704990)
1. Expression level of quiescin sulfhydryl oxidase 1 (QSOX1) in neuroblastomas.
Araújo DG; Nakao L; Gozzo P; Souza CD; Balderrama V; Gugelmin ES; Kuczynski AP; Olandoski M; de Noronha L
Eur J Histochem; 2014 Mar; 58(1):2228. PubMed ID: 24704990
[TBL] [Abstract][Full Text] [Related]
2. Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Katchman BA; Ocal IT; Cunliffe HE; Chang YH; Hostetter G; Watanabe A; LoBello J; Lake DF
Breast Cancer Res; 2013 Mar; 15(2):R28. PubMed ID: 23536962
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of sulfhydryl oxidase (QSOX1) in pediatric medulloblastomas.
Sobral AC; Neto VM; Traiano G; Percicote AP; Gugelmin ES; de Souza CM; Nakao L; Torres LF; de Noronha L
Diagn Pathol; 2015 Apr; 10():37. PubMed ID: 25908093
[TBL] [Abstract][Full Text] [Related]
4. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of QSOX1 in cancer.
Lake DF; Faigel DO
Antioxid Redox Signal; 2014 Jul; 21(3):485-96. PubMed ID: 24359107
[TBL] [Abstract][Full Text] [Related]
6. QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.
Knutsvik G; Collett K; Arnes J; Akslen LA; Stefansson IM
Mod Pathol; 2016 Dec; 29(12):1485-1491. PubMed ID: 27562495
[TBL] [Abstract][Full Text] [Related]
7. Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.
Soloviev M; Esteves MP; Amiri F; Crompton MR; Rider CC
PLoS One; 2013; 8(2):e57327. PubMed ID: 23460839
[TBL] [Abstract][Full Text] [Related]
8. High expression of QSOX1 is associated with tumor invasiveness and high grades groups in prostate cancer.
Baek JA; Song PH; Ko Y; Gu MJ
Pathol Res Pract; 2018 Jul; 214(7):964-967. PubMed ID: 29804717
[TBL] [Abstract][Full Text] [Related]
9. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
10. Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis.
Sung HJ; Ahn JM; Yoon YH; Na SS; Choi YJ; Kim YI; Lee SY; Lee EB; Cho S; Cho JY
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336636
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
[TBL] [Abstract][Full Text] [Related]
12. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
[TBL] [Abstract][Full Text] [Related]
13. Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.
Katchman BA; Antwi K; Hostetter G; Demeure MJ; Watanabe A; Decker GA; Miller LJ; Von Hoff DD; Lake DF
Mol Cancer Res; 2011 Dec; 9(12):1621-31. PubMed ID: 21989104
[TBL] [Abstract][Full Text] [Related]
14. Quiescin sulfhydryl oxidase (QSOX) is expressed in the human atheroma core: possible role in apoptosis.
de Andrade CR; Stolf BS; Debbas V; Rosa DS; Kalil J; Coelho V; Laurindo FR
In Vitro Cell Dev Biol Anim; 2011 Dec; 47(10):716-27. PubMed ID: 22069028
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity as a prognostic factor in neuroblastomas.
Streutker CJ; Thorner P; Fabricius N; Weitzman S; Zielenska M
Pediatr Dev Pathol; 2001; 4(1):62-7. PubMed ID: 11200492
[TBL] [Abstract][Full Text] [Related]
16. High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients.
Pernodet N; Hermetet F; Adami P; Vejux A; Descotes F; Borg C; Adams M; Pallandre JR; Viennet G; Esnard F; Jouvenot M; Despouy G
Breast Cancer Res; 2012 Oct; 14(5):R136. PubMed ID: 23098186
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuroblastic tumours in eastern Denmark 1972-2002.
Zimling ZG; Rechnitzer C; Rasmussen M; Petersen BL
APMIS; 2007 Jan; 115(1):66-74. PubMed ID: 17223852
[TBL] [Abstract][Full Text] [Related]
18. Different characteristics of neuroblastomas in cases found by mass screening and non-screening: evaluation of mass screening for neuroblastoma in Kitakyushu City.
Ariyoshi N
J UOEH; 1993 Dec; 15(4):251-66. PubMed ID: 8265887
[TBL] [Abstract][Full Text] [Related]
19. High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas.
Ramani P; Sowa-Avugrah E; May MT
Virchows Arch; 2015 Sep; 467(3):319-27. PubMed ID: 26199132
[TBL] [Abstract][Full Text] [Related]
20. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]